IELSG30 phase 2 trial: intravenous and intrathecal CNS prophylaxis in primary testicular diffuse large B-cell lymphomaAnnarita Conconi, Emanuele Zucca, Annalisa Chiappella et al.|Blood Advances|2024Cited by 29
Long-term follow-up of rituximab plus bendamustine and cytarabine in older patients with newly diagnosed MCLMaria Chiara Tisi, Carlo Visco, Simone Ferrero et al.|Blood Advances|2023Cited by 23